Source recordFED

Sekisui Diagnostics PEI Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2020· $297,389· BN 836576355· PE

Description

The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications for a Sekisui branded Vitamin D reagent.

Amendment chain · 8 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $423,604 at start, $297,389 after amendment #8 (−$126,215).

$423,604$0Original · 2019-04-15 (start date) · total $423,604Amendment 1 · 2019-12-04 · total $335,574Amendment 2 · 2020-11-16 · total $263,824Amendment 3 · 2021-02-10 · total $255,324Amendment 5 · 2022-03-10 · total $255,324Amendment 6 · 2022-09-29 · total $316,324Amendment 7 · 2023-02-01 · total $316,324Amendment 8 · 2023-06-15 · total $297,389
  • #02019-04-15$423,604
  • #12019-12-04$335,574-$88,030
  • #22020-11-16$263,824-$71,750
  • #32021-02-10$255,324-$8,500
  • #52022-03-10$255,324
  • #62022-09-29$316,324+$61,000
  • #72023-02-01$316,324
  • #82023-06-15$297,389-$18,935
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2019-04-15(start date)$423,604—The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#1 amendment2019-12-04$335,574−$88,030The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#2 amendment2020-11-16$263,824−$71,750The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#3 amendment2021-02-10$255,324−$8,500The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#5 amendment2022-03-10$255,324+$0The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#6 amendment2022-09-29$316,324+$61,000The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#7 amendment2023-02-01$316,324+$0The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…
#8 amendment2023-06-15$297,389−$18,935The purpose of the project is to develop the formulation, scale up manufacturing and instrument applications f…

Related records · 7

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 836576355)

RefDepartment · programCurrent valueFY
172-2020-2021-Q1-947607National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$285,794FY2021
172-2018-2019-Q2-912866National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$9,945FY2019

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q1-927284 · retrieved 2026-11-15.